Specialized pro-resolving mediators (SPMs) are lipid mediators derived from poly-unsaturated fatty acids (PUFAs) which have been demonstrated to have an important role in the inflammation environment, preventing an overreaction of the organism and promoting the resolution of inflammation. Our purpose was to point out the current evidence for specialized pro-resolving mediators, focusing on their role in neuroinflammation and in major neurological diseases
Dietary polyunsaturated fatty acids (PUFAs) have gained more importance these last decades since the...
Ischemic stroke contributes to ~80% of all stroke cases. Recanalization with thrombolysis or endovas...
The role of n-3 PUFAs has gained more importance these last decades, especially in inflammatory proc...
Alzheimer’s disease (AD) and Parkinson’s disease (PD) are neurodegenerative disorders that affect mi...
Unresolved inflammation is central to the pathophysiology of commonly occurring vascular diseases su...
Astrocytes and oligodendrocytes are known to play critical roles in the central nervous system devel...
Specialized proresolving mediators (SPMs) are a novel class of endogenous lipids, derived by ω-6 and...
Abstract Inflammation is an essential mechanism of various diseases. The development and resolution ...
In the last twenty years an impressive body of evidence in diverse inflammatory animal disease model...
Within this chapter we discuss the mechanisms that drive inflammation resolution and consider the po...
Diminished lymphatic function and abnormal morphology are common in chronic inflammatory diseases. R...
Atherosclerosis is one of the most important problems of modern medicine as it is the leading cause ...
Diminished lymphatic function and abnormal morphology are common in chronic inflammatory diseases. R...
A precision medicine approach is widely acknowledged to yield more effective therapeutic strategies ...
Acute inflammation has been described as a reactive dynamic process, promoted by the secretion of pr...
Dietary polyunsaturated fatty acids (PUFAs) have gained more importance these last decades since the...
Ischemic stroke contributes to ~80% of all stroke cases. Recanalization with thrombolysis or endovas...
The role of n-3 PUFAs has gained more importance these last decades, especially in inflammatory proc...
Alzheimer’s disease (AD) and Parkinson’s disease (PD) are neurodegenerative disorders that affect mi...
Unresolved inflammation is central to the pathophysiology of commonly occurring vascular diseases su...
Astrocytes and oligodendrocytes are known to play critical roles in the central nervous system devel...
Specialized proresolving mediators (SPMs) are a novel class of endogenous lipids, derived by ω-6 and...
Abstract Inflammation is an essential mechanism of various diseases. The development and resolution ...
In the last twenty years an impressive body of evidence in diverse inflammatory animal disease model...
Within this chapter we discuss the mechanisms that drive inflammation resolution and consider the po...
Diminished lymphatic function and abnormal morphology are common in chronic inflammatory diseases. R...
Atherosclerosis is one of the most important problems of modern medicine as it is the leading cause ...
Diminished lymphatic function and abnormal morphology are common in chronic inflammatory diseases. R...
A precision medicine approach is widely acknowledged to yield more effective therapeutic strategies ...
Acute inflammation has been described as a reactive dynamic process, promoted by the secretion of pr...
Dietary polyunsaturated fatty acids (PUFAs) have gained more importance these last decades since the...
Ischemic stroke contributes to ~80% of all stroke cases. Recanalization with thrombolysis or endovas...
The role of n-3 PUFAs has gained more importance these last decades, especially in inflammatory proc...